Navigation Links
Biotechnology Salutes America's Veterans; Innovations Continue to Offer Improved Treatment and Care of Combat Troops
Date:11/11/2009

On-the-battlefield surgical sealants, advancements in blood substitutes and stem cell treatments for bone and tissue re-growth

WASHINGTON, Nov. 11 /PRNewswire-USNewswire/ -- The WhatCanBiotechDoForYou campaign saluted American veterans across the country today for their service in defense of the United States. The biotechnology industry has consistently supported these brave men and women, both veterans and current soldiers, through innovative breakthroughs in medical treatment on and off the battlefield. Today, these innovations include on-the-battlefield surgical sealants, advancements in blood substitutes and stem cell treatments for bone and tissue re-growth after traumatic injuries.

A WhatCanBiotechDoForYou campaign spokesperson said today, "Today every American honors the commitment and sacrifices made by our veterans in defense of the United States. We are proud to be at the forefront of lifesaving treatments for our heroes wounded in action and will continue to honor their dedication to us with our dedication to advancing the biotechnologies needed to care for them."

The WhatCanBiotechDoForYou campaign outlined many of these advancements today in a post on its website, www.whatcanbiotechdoforyou.com. They include:

  • BioFoam, a surgical sealant developed by Georgia-based CryoLife, seals large, life-threatening wounds almost immediately on the battlefield. The substance is contained in a two-chamber applicator and upon contact, expands five-fold into a foam which sets within 15 to 20 seconds and reaches full bonding strength within two minutes. The research is currently in animal trials and testing.
  • The military has worked for an alternative to human blood for a decade to no avail. The DoD is in discussions with HemoBioTech of Dallas, Texas who may have solved the riddle. Previous attempts at developing blood substitutes resulted in problems with toxicity; however, the FDA has cited this technology (last April) at a blood substitute meeting as a promising new-generation strategy.
  • Another separate technology holds hope to dramatically help soldiers re-grow bone and tissue after traumatic injuries. Georgia Tech researchers have discovered that stem cells, when encapsulated in microbeads, can be injected and stay at injury sites for up to two months, eventually transforming into the cells which grow bone and tissue. The technology is currently in pre-clinical stages.

To learn more about advancements in the biotechnology industry related to care for our soldiers and the biotechnology industry in general, visit www.WhatCanBiotechDoForYou.com or www.IAmBiotech.org.

About WhatCanBiotechDoForYou.com

WhatCanBiotechDoForYou.com is part of a project sponsored by the Biotechnology Industry Organization (BIO), designed to foster a conversation with the general public about biotechnology and further educate people about the contributions of this innovative sector. For more in-depth information on biotech and the people behind the science, please visit our sister site - www.IAmBiotech.org.

SOURCE The WhatCanBiotechDoForYou campaign


'/>"/>
SOURCE The WhatCanBiotechDoForYou campaign
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
6. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
10. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
11. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the upcoming 2016 Miss Arizona pageant as its official Medspa Sponsor. Dr. Josh ... Mesa, and Chandler, Arizona. , Dr. Olson says the decision to support ...
(Date:6/24/2016)... New York (PRWEB) , ... June 24, 2016 , ... ... marijuana patients optimize the ingestion of their medication by matching users with high quality ... users to compare pieces with no commitment. , Inhale was founded by two brothers, ...
Breaking Medicine News(10 mins):